ofloxacin has been researched along with Empyema, Thoracic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiner, E; Ferrufino, E; Mejía, C; Ortiz de la Tabla, V | 1 |
Bouros, DE; Kottakis, I; Liapakis, IE; Light, RW; Pitiakoudis, MS; Simopoulos, CE; Tsatsakis, AM; Tzatzarakis, MN; Ypsilantis, P | 1 |
Brückner, O; Trautmann, M | 1 |
3 other study(ies) available for ofloxacin and Empyema, Thoracic
Article | Year |
---|---|
Empyema caused by Legionella pneumophila.
Topics: Acute-Phase Proteins; Aged; Antigens, Bacterial; beta-Lactams; Body Fluids; Cough; Drug Therapy, Combination; Dyspnea; Empyema, Pleural; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Ofloxacin; Tomography, X-Ray Computed | 2012 |
Penetration of newer quinolones in the empyema fluid.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Empyema, Pleural; Escherichia coli Infections; Fluoroquinolones; Levofloxacin; Male; Moxifloxacin; Ofloxacin; Pleural Effusion; Quinolines; Rabbits | 2004 |
Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bronchitis; Cefixime; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Empyema, Pleural; Humans; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Safety; Treatment Outcome | 1989 |